Mehra Anand 4
4 · Aclaris Therapeutics, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Mehra Anand
Director
Transactions
- Purchase
Common Stock
2024-11-19$2.25/sh+666,666$1,499,999→ 710,030 total
Footnotes (1)
- [F1]Represents shares of Common Stock of the Issuer acquired from the Issuer pursuant to Rule 16b-3(d).